02-10-2023 01:20 PM | Source: Sushil Finance
Buy Kilitch Drugs (India) Ltd For Target Rs.254 - Sushil Finance
We have coverage on Kilitch Drugs (India) Ltd with a BUY rating on stock. Since our report, the stock has posted a high of Rs.244 today
With the recent run-up in the share price (36% return), we are now changing our rating on the stock to Neutral and recommend our investors to book profits.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report & Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer
Latest News
KP Energy shines on bagging new orders of 1003.7 MW ...
NTPC rises on inking JV agreement with RVUNL
Exploring famous foods from different countries
Samsung Tops India`s Smartphone Market with 23% Valu...
India`s Apollo Green Energy plans solar module plant...
Family-Friendly Activities in the Mountains
India HPCL plans to buy 43% more Iraqi oil in 2025, ...
Centre launches phase 2 of subsidised Bharat Atta, R...
Monthly Auto Sales - October 2024 by Arete Securitie...
India`s home textiles industry to see 6-8 pc growth ...